chr3-113866786-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_017577.5(GRAMD1C):c.175-2721T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.33 in 151,874 control chromosomes in the GnomAD database, including 8,794 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.33   (  8794   hom.,  cov: 32) 
Consequence
 GRAMD1C
NM_017577.5 intron
NM_017577.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.214  
Publications
12 publications found 
Genes affected
 GRAMD1C  (HGNC:25252):  (GRAM domain containing 1C) Predicted to enable cholesterol binding activity and cholesterol transfer activity. Predicted to be involved in cellular response to cholesterol. Predicted to be located in endoplasmic reticulum membrane; endoplasmic reticulum-plasma membrane contact site; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89). 
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.372  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GRAMD1C | NM_017577.5  | c.175-2721T>C | intron_variant | Intron 2 of 17 | ENST00000358160.9 | NP_060047.3 | ||
| GRAMD1C | XM_011512930.2  | c.145-2721T>C | intron_variant | Intron 2 of 17 | XP_011511232.1 | |||
| GRAMD1C | XM_005247547.3  | c.175-2721T>C | intron_variant | Intron 2 of 16 | XP_005247604.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.330  AC: 50129AN: 151758Hom.:  8787  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
50129
AN: 
151758
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.330  AC: 50161AN: 151874Hom.:  8794  Cov.: 32 AF XY:  0.332  AC XY: 24643AN XY: 74222 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
50161
AN: 
151874
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
24643
AN XY: 
74222
show subpopulations 
African (AFR) 
 AF: 
AC: 
9774
AN: 
41444
American (AMR) 
 AF: 
AC: 
5799
AN: 
15272
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1043
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
1358
AN: 
5168
South Asian (SAS) 
 AF: 
AC: 
1170
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
4422
AN: 
10446
Middle Eastern (MID) 
 AF: 
AC: 
68
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
25534
AN: 
67940
Other (OTH) 
 AF: 
AC: 
665
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.498 
Heterozygous variant carriers
 0 
 1641 
 3282 
 4923 
 6564 
 8205 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 502 
 1004 
 1506 
 2008 
 2510 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
957
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.